252 related articles for article (PubMed ID: 18505774)
1. Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.
Sternberg Z; Weinstock-Guttman B; Hojnacki D; Zamboni P; Zivadinov R; Chadha K; Lieberman A; Kazim L; Drake A; Rocco P; Grazioli E; Munschauer F
Mult Scler; 2008 Jul; 14(6):759-63. PubMed ID: 18505774
[TBL] [Abstract][Full Text] [Related]
2. Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
Lutterotti A; Kuenz B; Gredler V; Khalil M; Ehling R; Gneiss C; Egg R; Deisenhammer F; Berger T; Reindl M
J Neuroimmunol; 2006 Dec; 181(1-2):145-9. PubMed ID: 17046070
[TBL] [Abstract][Full Text] [Related]
3. Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2009 Aug; 120(2):119-22. PubMed ID: 19053950
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
Benesová Y; Vasku A; Novotná H; Litzman J; Stourac P; Beránek M; Kadanka Z; Bednarík J
Mult Scler; 2009 Mar; 15(3):316-22. PubMed ID: 19153173
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.
Emanuele E; D'Angelo A; Tomaino C; Binetti G; Ghidoni R; Politi P; Bernardi L; Maletta R; Bruni AC; Geroldi D
Arch Neurol; 2005 Nov; 62(11):1734-6. PubMed ID: 16286548
[TBL] [Abstract][Full Text] [Related]
7. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
[TBL] [Abstract][Full Text] [Related]
8. Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis.
Sternberg Z; Sternberg D; Drake A; Chichelli T; Yu J; Hojnacki D
J Neuroimmunol; 2014 Sep; 274(1-2):197-201. PubMed ID: 25064498
[TBL] [Abstract][Full Text] [Related]
9. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
10. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study.
Hájek Z; Germanová A; Koucký M; Zima T; Kopecký P; Vítkova M; Parízek A; Kalousová M
J Perinat Med; 2008; 36(5):399-404. PubMed ID: 18771410
[TBL] [Abstract][Full Text] [Related]
11. Soluble receptor for advanced glycation end products in patients with decreased renal function.
Kalousová M; Hodková M; Kazderová M; Fialová J; Tesar V; Dusilová-Sulková S; Zima T
Am J Kidney Dis; 2006 Mar; 47(3):406-11. PubMed ID: 16490618
[TBL] [Abstract][Full Text] [Related]
12. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
[TBL] [Abstract][Full Text] [Related]
13. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
Tesarová P; Kalousová M; Jáchymová M; Mestek O; Petruzelka L; Zima T
Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
[TBL] [Abstract][Full Text] [Related]
14. Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease.
Yilmaz Y; Ulukaya E; Gul OO; Arabul M; Gul CB; Atug O; Oral AY; Aker S; Dolar E
Clin Biochem; 2009 Jun; 42(9):802-7. PubMed ID: 19217891
[TBL] [Abstract][Full Text] [Related]
15. The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease.
Catalano M; Cortelazzo A; Santi R; Contino L; Demicheli M; Yilmaz Y; Zorzetto M; Campo I; Lanati N; Emanuele E
Clin Biochem; 2008 Aug; 41(12):981-5. PubMed ID: 18538667
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
[TBL] [Abstract][Full Text] [Related]
17. sICAM-1 is not a marker for disease activity in the relapse-free interval of multiple sclerosis--a cross-sectional pilot study.
Flachenecker P; Jung S; Rieckmann P; Toyka KV
J Neurol; 2002 Aug; 249(8):1001-3. PubMed ID: 12195444
[TBL] [Abstract][Full Text] [Related]
18. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.
Falcone C; Emanuele E; D'Angelo A; Buzzi MP; Belvito C; Cuccia M; Geroldi D
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1032-7. PubMed ID: 15731496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
